$10.080
-0.020 (-0.20%)At close
- High
- 10.080
- Open
- 10.080
- VWAP
- 10.08
- Volume
- 20.06K
- Mkt Cap
- 48.97M
- Low
- 10.080
- Amount
- 202.18K
- EV/EBITDA, TTM
- 0.00
Breeze Acquisition Corp. II is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search on companies with global operations and differentiated technology or capabilities, particularly in healthcare, biotechnology, advanced manufacturing, robotics, artificial intelligence, and related sectors. The Company has not generated any operating revenues.
AI analysis of Breeze Acquisition Corp II (BREZ)
HoldBreeze Acquisition Corp II (BREZ) is currently priced at $10.07, showing a 52-week high of $10.14 and a low of $9.90, which indicates it is trading near the higher end of its range. The RSI is at 55.109, suggesting the stock is neither overbought nor oversold. However, the current ratio has improved significantly to 2.91 in Q2 from 0.05 in Q1, indicating better liquidity. The stock's performance has been stable with a year-to-date change of +1.51%. The main risk is the recent news about the challenges facing low-cost airlines, which could impact future profitability. Given the current price stability and lack of strong catalysts, a hold position is recommended for now.
Valuation Metrics
Events Timeline
News
8.506-20CNBCDecline of Low-Cost Airline Options in the U.S.
8.505-13NewsfilterBreeze Acquisition Corp. II Prices IPO at $10 per Unit
8.508-15NewsfilterBreeze Holdings Acquisition Corp. Shareholders Approve Business Combination with YD Biopharma Limited
8.509-25NewsfilterBreeze Holdings Acquisition Corp. Announces Definitive Agreement to Merge with YD Biopharma Limited
2.008-21NewsfilterBreeze Holdings Acquisition Corp. Provides Update on Trading Status and Potential Business Combination
BREZ FAQ — answered by Alphio AI
Breeze Acquisition Corp. II is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search on companies with global operations and differentiated technology or capabilities, particularly in healthcare, biotechnology, advanced manufacturing, robotics, artificial intelligence, and related sectors. The Company has not generated any operating revenues. It operates in the Financials sector (BLANK CHECKS industry).
Breeze Acquisition Corp II (BREZ) is currently priced at $10.07, showing a 52-week high of $10.14 and a low of $9.90, which indicates it is trading near the higher end of its range. The RSI is at 55.109, suggesting the stock is neither overbought nor oversold. However, the current ratio has improved significantly to 2.91 in Q2 from 0.05 in Q1, indicating better liquidity. The stock's performance has been stable with a year-to-date change of +1.51%. The main risk is the recent news about the challenges facing low-cost airlines, which could impact future profitability. Given the current price stability and lack of strong catalysts, a hold position is recommended for now.
Community
More ↗No posts yet
Sign up or log in to join the discussionRelated articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.